← FDA DRUG APPROVALS

FDA NDA · NDA006459

HETRAZAN

Sponsor: LEDERLE

APPLICATION
NDA006459
TYPE
NDA
ORIGINAL APPROVAL
1950-11-13
LATEST ACTION
1991-05-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HETRAZANDiscontinued
DIETHYLCARBAMAZINE CITRATE 50MG · TABLET · ORAL

Approval history

1991-05-10Manufacturing (CMC) · Supplement 7AP
1991-02-28Manufacturing (CMC) · Supplement 6AP
1985-06-07Manufacturing (CMC) · Supplement 4AP
1985-06-07Labeling · Supplement 2AP
1985-06-07Manufacturing (CMC) · Supplement 5AP
1985-06-07Manufacturing (CMC) · Supplement 3AP
1950-11-13UNKNOWN · Original · unknownAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →